Cite
Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations.
MLA
Eckardt, Jan-Niklas, et al. “Molecular Profiling and Clinical Implications of Patients with Acute Myeloid Leukemia and Extramedullary Manifestations.” Journal of Hematology & Oncology, vol. 15, no. 1, May 2022, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s13045-022-01267-7.
APA
Eckardt, J.-N., Stölzel, F., Kunadt, D., Röllig, C., Stasik, S., Wagenführ, L., Jöhrens, K., Kuithan, F., Krämer, A., Scholl, S., Hochhaus, A., Crysandt, M., Brümmendorf, T. H., Naumann, R., Steffen, B., Kunzmann, V., Einsele, H., Schaich, M., Burchert, A., & Neubauer, A. (2022). Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations. Journal of Hematology & Oncology, 15(1), 1–13. https://doi.org/10.1186/s13045-022-01267-7
Chicago
Eckardt, Jan-Niklas, Friedrich Stölzel, Desiree Kunadt, Christoph Röllig, Sebastian Stasik, Lisa Wagenführ, Korinna Jöhrens, et al. 2022. “Molecular Profiling and Clinical Implications of Patients with Acute Myeloid Leukemia and Extramedullary Manifestations.” Journal of Hematology & Oncology 15 (1): 1–13. doi:10.1186/s13045-022-01267-7.